4D Pharma PLC (LBPS) Stock Analyst Ratings
USA - NASDAQ:LBPS - US35085K1097 - ADR
1.65
+0.04 (+2.48%)
ChartMill assigns a Buy % Consensus number of 80% to LBPS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.52. This target is 356.04% above the current price.
LBPS was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about LBPS.
In the previous month the buy percentage consensus was at a similar level.
LBPS was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-06-27 | Chardan Capital | Downgrade | Buy -> Neutral |
4D Pharma PLC / LBPS FAQ
What is the average price target for 4D Pharma PLC (LBPS) stock?
6 analysts have analysed LBPS and the average price target is 7.52 null. This implies a price increase of 356.04% is expected in the next year compared to the current price of 1.65.
What is the consensus rating for LBPS stock?
The consensus rating for 4D Pharma PLC (LBPS) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed 4D Pharma PLC (LBPS)?
The number of analysts covering 4D Pharma PLC (LBPS) is 6.